Insider and congress filings

ResMed Inc. (RMD)

NYSE · Healthcare · 328 insider filings · 51 congress trades · last filed yesterdayS&P 500

20
Open-market insider filings shown
2d
Median delay on the insider filings
within the two business day rule
0/20
Purchases and sales in the filings shown

About ResMed Inc.

from the company's filings and listing
Exchange
NYSE
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Chief executive
Michael J. Farrell
Employees
11,370
Listed since
Jun 2, 1995
Market value
$31.9B
Price to earnings
21.1
Earnings per share
$10.53
Dividend yield
1.12%

www.resmed.com

Earnings

6 reported quarters · next on Oct 29, 2026
QuarterEPSEPS expectedRevenueRevenue expectedResult
Q4 FY2026reported Aug 6, 2026$2.95$2.89$1.5B$1.5BEPS beatRevenue in line
Q3 FY2026reported Apr 30, 2026$2.86$2.80$1.4B$1.4BEPS beatRevenue in line
Q2 FY2026reported Jan 29, 2026$2.81$2.74$1.4B$1.4BEPS beatRevenue beat
Q1 FY2026reported Oct 30, 2025$2.55$2.51$1.3B$1.3BEPS beatRevenue in line
Q4 FY2025reported Jul 31, 2025$2.55$2.46$1.3B$1.3BEPS beatRevenue in line
Q3 FY2025reported Apr 23, 2025$2.37$2.38$1.3B$1.3BEPS in lineRevenue in line

Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.

Institutional holders

13F positions as of Jun 30, 2026
HolderValueSharesChangeOf company
Blackrock, Inc.$2.4B12,317,194+1.8%8.51%
Vanguard Capital Management LLC$1.8B9,474,129+0.1%6.55%
Vanguard Portfolio Management LLC$1.5B7,913,661+0.6%5.47%
State Street Corp$1.3B6,680,735+0.6%4.62%
Geode Capital Management, LLC$845.2M4,352,320-0.0%3.01%
Bank Of New York Mellon Corp$818.0M4,197,610-14.8%2.90%
First Trust Advisors LP$444.1M2,278,696+48.2%1.57%
Invesco Ltd.$402.1M2,063,578+5.5%1.43%
Morgan Stanley$375.9M1,928,931-28.2%1.33%
Northern Trust Corp$330.6M1,696,674-1.7%1.17%
Nordea Investment Management Ab$269.6M1,388,008+34.3%0.96%
Deutsche Bank Ag\$257.7M1,322,313-7.1%0.91%

A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.

Know the moment the next RMD filing lands.

GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.

Open-market insider trades

20 filings of 328 on record
InsiderActionSharesPriceValueTrade dateDelay
Michael J. FarrellChairman and CEOSold · scheduled4,991$222.44$1.1MSep 8, 20262d
Peter C. FarrellDirectorSold970$234.73$228KSep 2, 20262d
Michael J. FarrellChairman and CEOSold4,991$205.69$1.0MAug 7, 20264d
Peter C. FarrellDirectorSold8,000$225.00$1.8MAug 5, 20261d
Michael J. FarrellChairman and CEOSold4,991$218.55$1.1MJul 7, 20262d
Michael J. FarrellChairman and CEOSold4,991$193.96$968KJun 8, 20261d
Michael J. FarrellChairman and CEOSold4,991$207.82$1.0MMay 7, 20264d
Michael J. FarrellChairman and CEOSold4,991$225.50$1.1MApr 7, 20262d
Brett SandercockChief Financial OfficerSold1,000$224.31$224KApr 1, 20262d
Peter C. FarrellDirectorSold2,000$225.00$450KApr 1, 20261d
Michael J. FarrellChairman and CEOSold4,991$251.03$1.3MMar 9, 20262d
Peter C. FarrellDirectorSold2,000$260.22$520KMar 4, 20261d
Brett SandercockChief Financial OfficerSold1,000$254.30$254KMar 2, 20261d
Michael J. FarrellChairman and CEOSold4,991$273.78$1.4MFeb 9, 20261d
Peter C. FarrellDirectorSold2,000$251.31$503KFeb 4, 20262d
Michael J. RiderGlobal General CounselSold50$260.00$13KFeb 4, 20262d
Brett SandercockChief Financial OfficerSold1,000$257.03$257KFeb 2, 20261d
Peter C. FarrellDirectorSold2,000$248.83$498KJan 7, 20262d
Michael J. FarrellChairman and CEOSold4,991$248.46$1.2MJan 7, 20261d
Brett SandercockChief Financial OfficerSold1,000$241.75$242KJan 2, 20263d

One row is one filing. A filing that reported its trade in several tranches is summed, priced at the weighted average, and marked with its line count.

Congress trades in RMD

20 disclosures of 51 on record · median 17d of the 45 allowed
MemberTypeActionAmount disclosedSince the tradeTrade dateDisclosedDelay
Ro KhannaStockPurchase$1,001 - $15,000+2.2%S&P +0.6% · vs S&P 500 +1.6%Aug 3, 2026Sep 4, 202632d
Alan ArmstrongSelfFiled lateStockPurchase$1,001 - $15,000-0.2%S&P +20.2% · vs S&P 500 -20.5%Mar 27, 2026Jul 21, 2026116d
Ro KhannaStockPurchase$1,001 - $15,000+13.4%S&P +1.6% · vs S&P 500 +11.8%Jun 16, 2026Jul 6, 202620d
Ro KhannaStockSale$1,001 - $15,000+12.9%S&P +2.1% · vs S&P 500 +10.8%Jun 30, 2026Jul 6, 20266d
Ro KhannaStockPurchase$1,001 - $15,000+6.7%S&P +1.6% · vs S&P 500 +5.1%May 27, 2026Jun 9, 202613d
Ro KhannaStockPurchase$1,001 - $15,000+7.3%S&P +5.8% · vs S&P 500 +1.5%May 1, 2026Jun 9, 202639d
Ro KhannaStockSale$1,001 - $15,000+9.0%S&P +3.2% · vs S&P 500 +5.8%May 15, 2026Jun 9, 202625d
Ro KhannaStockPurchase$1,001 - $15,000-4.5%S&P +11.1% · vs S&P 500 -15.6%Apr 13, 2026May 11, 202628d
Ro KhannaStockPurchase$1,001 - $15,000+0.1%S&P +6.8% · vs S&P 500 -6.7%Apr 24, 2026May 11, 202617d
Ro KhannaStockSale$1,001 - $15,000-3.5%S&P +16.0% · vs S&P 500 -19.5%Mar 23, 2026Apr 7, 202615d
Ro KhannaStockSale$1,001 - $15,0000.0%S&P +20.7% · vs S&P 500 -20.7%Mar 30, 2026Apr 7, 20268d
Ro KhannaStockPurchase$1,001 - $15,000-12.6%S&P +10.9% · vs S&P 500 -23.4%Feb 24, 2026Mar 9, 202613d
Ro KhannaStockSale$1,001 - $15,000-12.8%S&P +10.6% · vs S&P 500 -23.4%Jan 23, 2026Feb 6, 202614d
Ro KhannaStockSale$1,001 - $15,000-11.4%S&P +10.9% · vs S&P 500 -22.3%Jan 29, 2026Feb 6, 20268d
Kelly MorrisonStockSale$1,001 - $15,000-12.2%S&P +28.2% · vs S&P 500 -40.4%Jun 4, 2025Jun 18, 202514d
Ro KhannaStockPurchase$1,001 - $15,000-10.1%S&P +29.7% · vs S&P 500 -39.9%May 28, 2025Jun 10, 202513d
Kelly MorrisonStockSale$1,001 - $15,000-6.3%S&P +38.6% · vs S&P 500 -44.9%Apr 28, 2025May 13, 202515d
Ro KhannaStockSale$1,001 - $15,000+2.6%S&P +42.4% · vs S&P 500 -39.9%Apr 23, 2025May 12, 202519d
Ro KhannaStockPurchase$1,001 - $15,000-1.8%S&P +33.7% · vs S&P 500 -35.4%Mar 6, 2025Apr 10, 202535d
Robert BresnahanJointStockSale$1,001 - $15,000-4.5%S&P +31.1% · vs S&P 500 -35.6%Jan 13, 2025Feb 13, 202531d

Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 10, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.

Members of Congress reporting a position

3 members · estimate, as of Sep 10, 2026

3 members report a position (estimated). The largest estimated position is in the $1,001 - $15,000 band.

MemberParty, chamberEstimated positionShare of their portfolio
Robert BresnahanRepublican · House$1,001 - $15,0000.1%
Gilbert Ray Cisneros, Jr.Democrat · House$1,001 - $15,000<0.1%
Julie JohnsonDemocrat · House$1,001 - $15,0000.1%

Estimate, as of Sep 10, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, moved with the stock's price since the trade. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.

Awards, option exercises and gifts (20)
InsiderEventSharesDate
Michael J. FarrellChairman and CEOOption exercise4,991Sep 8, 2026
Michael J. FarrellChairman and CEOOption exercise4,991Aug 7, 2026
Michael J. FarrellChairman and CEOOption exercise4,991Jul 7, 2026
Michael J. FarrellChairman and CEOOption exercise4,991Jun 8, 2026
Michael J. FarrellChairman and CEOOption exercise4,991May 7, 2026
Michael J. FarrellChairman and CEOOption exercise4,991Apr 7, 2026
Michael J. FarrellChairman and CEOOption exercise4,991Mar 9, 2026
Michael J. FarrellChairman and CEOOption exercise4,991Feb 9, 2026
Michael J. FarrellChairman and CEOOption exercise4,991Jan 7, 2026
Michael J. FarrellChairman and CEOOption exercise4,991Dec 8, 2025
Michael J. FarrellChairman and CEOStock award33,288Nov 24, 2025
Peter C. FarrellDirectorStock award1,331Nov 24, 2025
Nicole Mowad-NassarDirectorStock award1,331Nov 24, 2025
John HernandezDirectorStock award1,073Nov 20, 2025
Christopher DelOreficeDirectorStock award1,073Nov 20, 2025
Michael J. FarrellChairman and CEOTax withholding7,297Nov 20, 2025
Michael J. FarrellChairman and CEOStock award13,551Nov 20, 2025
Brett SandercockChief Financial OfficerStock award2,710Nov 20, 2025
Ronald R. TaylorDirectorStock award1,073Nov 20, 2025
Carol BurtDirectorStock award1,073Nov 20, 2025

Awards, option exercises, shares withheld to cover tax and gifts all file on the same form as a purchase or a sale. None of them is a decision to trade, so they sit here rather than beside the ones that are.

Questions

Are insiders buying or selling RMD?

Across the 20 most recent open-market filings shown here, 0 were purchases and 20 were sales. One was scheduled in advance under a Rule 10b5-1 plan.

Which members of Congress have traded RMD?

Ro Khanna, Alan Armstrong, Kelly Morrison, Robert Bresnahan disclosed RMD transactions in the filings shown here.

Which members of Congress hold RMD?

3 members of Congress report a position in RMD in the estimate we hold as of Sep 10, 2026. The three largest estimated positions belong to Robert Bresnahan, Gilbert Ray Cisneros, Jr. and Julie Johnson. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.

Is RMD in the S&P 500 or the Nasdaq 100?

ResMed Inc. is a current member of the S&P 500, per the membership list we hold as of Sep 10, 2026. Current members of either index get a page here whatever their filing history.

How quickly are RMD trades disclosed?

Insider filings on this page reached the public a median of 2 days after the transaction, against the two business days Form 4 allows. Congressional disclosures took a median of 17 days, against the 45 the STOCK Act allows.

How to read a Form 4

A DECISION THE INSIDER MADE

POpen-market purchase. Bought with their own money at the market price.
SOpen-market sale. Sold on the market. A sale marked scheduled was set up in advance under a Rule 10b5-1 plan, often months before.

COMPENSATION PLUMBING

AStock award. Granted as pay, not bought.
MOption exercise. Converting options already held into shares.
FTax withholding. Shares handed back to the company to pay the tax on a grant.
GGift. Given away, with no money changing hands.

Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.

Data as of Sep 10, 2026.

Related companies

traded by the same members

See every company we track